Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C
| dc.contributor.author | Mitchell, T. | |
| dc.contributor.author | Chakera, Aron | |
| dc.contributor.author | Jeffrey, G. | |
| dc.contributor.author | Adams, L. | |
| dc.contributor.author | Garas, G. | |
| dc.contributor.author | Jones, T. | |
| dc.contributor.author | MacQuillan, G. | |
| dc.date.accessioned | 2017-07-27T05:20:07Z | |
| dc.date.available | 2017-07-27T05:20:07Z | |
| dc.date.created | 2017-07-26T11:11:21Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Mitchell, T. and Chakera, A. and Jeffrey, G. and Adams, L. and Garas, G. and Jones, T. and MacQuillan, G. 2016. Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C. Medical Journal of Australia. 205 (5): pp. 205-206. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/54205 | |
| dc.identifier.doi | 10.5694/mja16.00207 | |
| dc.publisher | Australasian Medical Publishing | |
| dc.title | Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C | |
| dc.type | Journal Article | |
| dcterms.source.volume | 205 | |
| dcterms.source.number | 5 | |
| dcterms.source.startPage | 205 | |
| dcterms.source.endPage | 206 | |
| dcterms.source.issn | 0025-729X | |
| dcterms.source.title | Medical Journal of Australia | |
| curtin.department | Curtin Medical School | |
| curtin.accessStatus | Fulltext not available |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||